In adult rat testes, the blood-testis barrier (BTB) in the seminiferous epithelium must ''open'' (or ''disassemble'') to accommodate the migration of preleptotene spermatocytes from the basal to the adluminal compartment that occurs at stage VIII of the epithelial cycle. However, the molecule(s) and/or mechanism(s) that regulate this event are unknown. In this report, C-type natriuretic peptide (CNP) was shown to be a regulator of BTB dynamics. Although Sertoli and germ cells contributed to the pool of CNP in the seminiferous epithelium, its receptor, natriuretic peptide receptor B, resided almost exclusively in Sertoli cells. CNP also expressed stage-specifically and localized predominantly at the BTB in the seminiferous epithelium at stage VIII of the epithelial cycle. A synthetic CNP-22 peptide, when added to Sertoli cell cultures, was shown to perturb Sertoli cell tight junction in vitro, causing disappearance of BTB-associated proteins (JAM-A, occludin, N-cadherin, and ␤-catenin) from the cell-cell interface. This inhibitory effect of CNP on the tight junction was confirmed by transient overexpression of CNP in these cells, which was mediated, at least in part, by accelerating the internalization of BTB integral membrane proteins. To validate these in vitro findings, CNP-22 was administered to testes at a dose of 0.35 or 3.5 g per testis, which was shown to perturb the BTB integrity in vivo when the barrier function was assessed by monitoring the diffusion of a small molecular probe across the BTB. In summary, CNP secreted by Sertoli and germ cells into the BTB microenvironment regulates BTB dynamics during spermatogenesis.
R
at atrial extracts were shown to contain a diuretic and natriuretic factor in a report published in 1981 (1) . Since then, three structurally related peptide hormones with vasodilatory properties, known as atrial natriuretic peptide (ANP), brain natriuretic peptide, and C-type natriuretic peptide (CNP), were isolated, molecularly cloned, and characterized (2) . Recent studies have shown that these natriuretic peptides regulate a variety of physiological functions in mammals including blood pressure, blood volume, fat metabolism, bone growth (3), and steroidogenesis in testes (4) . For instance, ANP was shown to stimulate testosterone and cGMP production in mouse Leydig cells in vitro (5) (6) (7) . ANP mRNA transcripts were detected in adult rat testes (8, 9) , and studies by immunohistochemistry also localized immunoreactive ANP to elongating spermatids and spermatozoa in the seminiferous epithelium of adult mouse and rat testes (10) . These studies thus illustrate the significance of these gonadal peptides in testis function (4) . These peptide hormones exert their biological effects on coupling onto the cell surface guanylyl cyclase (GC) receptors known as natriuretic peptide receptor (NPR)-A and NPR-B, which, in turn, catalyze the synthesis of the second messenger, cGMP, and determine the cGMP intracellular level (3, 11, 12) . Thus, NPR-A and NPR-B are also referred to as GC-A and GC-B, respectively. NPR-A is activated by ANP and brain natriuretic peptide, but not CNP, whereas CNP, but not ANP or brain natriuretic peptide, activates NPR-B (13, 14) . In addition, all three peptide hormones bind the natriuretic peptide clearance receptor (NPR-C) with similar affinities, but NPR-C lacks the intracellular kinase domain of NPR-A and NPR-B (15) . Recent studies have also shown that ANP acts as an antipermeability factor by blocking vascular permeability factor (also known as VEGF) signaling function, perturbing tight junction (TJ) protein phosphorylation and distribution in bovine aortic endothelial cells in vitro, such as occludin and zonula occludens 1 (ZO-1) (16) , illustrating that these peptides may have other biological functions besides modulating vascular dilation/constriction and steroidogenesis. Furthermore, cGMP, the downstream signaling molecule of natriuretic peptides, was shown to regulate Sertoli cell TJ permeability barrier function in vitro (17) . We thus sought to examine whether these peptide hormones would regulate junction restructuring events in adult rat testes, in particular the blood-testis barrier (BTB) during spermatogenesis. But because ANP was shown to be localized almost exclusively to the elongating/elongate spermatids in adult rat testes (10), we sought to examine the distribution of CNP and its receptor NPR-B in the testis. We also conducted a series of coherent experiments to examine the role of CNP in BTB dynamics.
Results

Expression of CNP in the Seminiferous Epithelium of Adult Rat Testes.
Sertoli and germ cells were shown to express CNP ( Fig. 1 A and B) by RT-PCR using RNA isolated from lysates of primary Sertoli or germ cell cultures. These cell preparations had negligible contamination of other cell types when their purity was assessed by RT-PCR and/or immunoblottings using primer pairs and/or antibodies specific to germ cells (e.g., c-kit receptor), Sertoli cells (e.g., testin), Leydig cells (e.g., 3␤-hydroxysteroid dehydrogenase), and peritubular myoid cells (e.g., fibronectin) as earlier reported (18) , and electron microscopy (17, 19) . Sertoli cells were shown to express more CNP than germ cells, but less than testes ( Fig. 1 A and  B) , suggesting that other cell types, such as Leydig cells, macrophages, endothelial cells of the microvessels in the interstitium, or peritubular myoid cells and/or endothelial cells of the lymphatic vessels in the tunica propria, also contributed to the steady-state CNP mRNA level in the testis. Indeed, results shown in Fig. 1C are consistent with this conclusion because positive CNP staining was found in the interstitium and immunoreactive CNP was detected in Leydig cells, macrophages, and/or endothelial cells ( Fig. 1 Cb and Cf ), similar to the findings of two earlier reports (20, 21) . The steady-state mRNA level of the CNP receptor NPR-B, however, was very low in germ cells vs. testes or Sertoli cells (Fig. 1 A) . The expression level of the clearance receptor NPR-C was also very low in Sertoli cells vs. germ cells (Fig. 1 A) . Collectively, these data illustrate that the Sertoli cell is the major cell type involved in the CNP-NPR-B-cGMP signaling in the seminiferous epithelium. By using an antibody specific to the CNP precursor (Fig. 1Cc) for immunohistochemistry, CNP was found to be localized to Leydig cells, macrophages, or endothelial cells in the interstitium, and its localization in the epithelium is consistent with its presence at the BTB (Fig. 1Cb) . These immunohistochemical data are consistent with the findings that Sertoli and Leydig cells (and perhaps endothelial cells and macrophages in the interstitium) contribute most of the CNP in the testis ( Fig. 1 A and B) . The CNP level in the seminiferous epithelium, such as the BTB, appeared to be stagespecific, being reduced at stages III-IV (Fig. 1Cd) , but remained relatively stable in other stages (see Fig. 1 Ce-Cg).
CNP Disrupts Tight and Anchoring Junctions in Sertoli Cells. Effects of using CNP synthetic peptide on Sertoli cell junction dynamics. We first examined the effects of CNP on Sertoli cell junctions by adding synthetic peptides to primary Sertoli cell cultures on day 4 when functional TJ, basal ectoplasmic specialization, and desmosomelike junctions were established as assessed by electron microscopy (19) (data not shown). Immunofluorescent staining of the junction proteins JAM-A, occludin, and N-cadherin, which are BTB-associated proteins, showed organized junction fibrils at the cell-cell interface in these cultures on day 4 ( Fig. 2 Aa, Ba, and Ca), consistent with earlier findings that intact TJ and anchoring junctions were present in these cultures. Furthermore, the TJ adaptor protein ZO-1 was also found to be at the cell-cell contact colocalizing with JAM-A or occludin, forming an almost continuous fluorescent belt at the cell-cell interface (Fig. 2 Ab, Ac, Bb, and Bc; see white arrowheads in Fig. 2 Ac, Bc, and Ca). ␤-Catenin was also restricted to the cell-cell interface (see white arrowheads in Fig.  2Cc ). Treatment of Sertoli cells with CNP at 1 ϫ 10 Ϫ6 M for 4 h, however, led to a disintegration of the almost continuous fluorescence belts at the cell-cell interface, illustrating a disruption of the TJ and anchoring junction protein fibrils (Fig. 2 Ad-Af, Bd-Bf, Cb, and Cd vs. Aa-Ac, Ba-Bc, Ca, and Cc). CNP treatment also caused an increase in nuclear localization of ␤-catenin (white arrows in Fig.  2Cd ). These results illustrate that the junctions were no longer intact after CNP treatment. Indeed, immunoblotting analysis of Sertoli cells treated with CNP for different durations showed that the levels of JAM-A, occludin, and N-cadherin began to decrease significantly after Ϸ3 h ( Fig. 2 D and E) . The p38 MAPK was also activated after CNP treatment, by Ϸ0.5 h, reaching a maximal activation by 1 h (Fig. 2 D 3 A and B) . The maximal levels of internalization of these proteins were detected after 1 h (Fig. 3 A and B) . Preliminary experiments showed that longer incubation at this temperature (normal physiological temperature of testes) did not result in a higher level of internalized proteins (data not shown), because endocytosed proteins underwent proteolysis and/or being recycled back to the cell surface (25) . Incubation at 18°C prevented the internalized proteins from further progressing into the endocytic or recycling pathway (25) , but the rate of internalization between these two temperatures did not differ significantly up to 1 h (data not shown). Moreover, this lower nonphysiological temperature seemed to insensitize the cellular responses to CNP treatment (data not shown). Therefore, these experiments were performed at 35°C for up to 1 h. Treatment of Sertoli cells with CNP at 1 ϫ 10 Ϫ6 M led to an acceleration of protein internalization (Fig. 3 A and B) . The maximal level of internalization after CNP treatment was reached by 30 min (Fig. 3  A and B) . These results demonstrated that integral membrane proteins at the BTB could be internalized, and the rate of internalization was up-regulated by the CNP peptide, which could be the mechanism by which CNP perturbed Sertoli cell junction dynamics as reported in Fig. 2 . Confocal microscopy studies. Confocal microscopy was used to corroborate the biochemical data that CNP promoted protein internalization at the BTB. Immediately after biotinylation of surface proteins (control: time 0), Sertoli cells were fixed and stained with FITC-streptavidin and an anti-occludin or anti-N-cadherin antibody ( Fig. 3 Ca-Cc and Da-Dc) in selected cultures. Biotin was detected at the cell-cell interface where junction proteins are localized (apposing white arrowheads in Fig. 3 Cc and Dc). Biotin was also found on the cell surface, showing even distribution of green fluorescence near the cell-cell interface (Fig. 3 Ca, Cc, Da, and Dc). In some Sertoli cell cultures, after cell surface biotinylation, cells were incubated in F12/DMEM for 30 min at 35°C to allow protein internalization, and the biotin remaining on the cell surface was removed. Biotinylated proteins appeared to be localized in punctate vesicles ( Fig. 3 Cd and Dd), which were shown to colocalize with dynamin (data not shown). Some of these endocytic vesicles were colocalized with occludin or N-cadherin (white arrows in Fig. 3 Cf and Df ), indicating previously biotinylated occludin and N-cadherin on the cell surface were indeed endocytosed. Treatment of cells with CNP at 10 Ϫ6 M (Fig. 3 Cg-Ci and Dg-Di) yielded more endocytic vesicles that were away from the cell-cell interface (white arrow in Fig. 3 Ci and Di), suggesting an acceleration of internalization of integral membrane proteins, possibly progressing into endosomes and/or lysosomes. These observations are consistent with data in Fig. 2 that CNP down-regulates BTB-associated proteins.
CNP Disrupts the BTB Integrity in Vivo. To further confirm that results of the in vitro studies regarding the effects of CNP on Sertoli cell junction dynamics were of physiologically significant, we sought to examine whether CNP peptide indeed regulated the BTB integrity in vivo. We thus examined whether treatment of testes with CNP synthetic peptide would alter the BTB integrity using a functional assay to monitor the diffusion of a small fluorescent dye, FITC (M r 389), across the BTB after its administration via the jugular vein (Fig. 4) . Because the BTB is a selective barrier that limits diffusion of small molecules from the systemic circulation into the seminiferous epithelium (26, 27) , it is not surprising that FITC was excluded from entering the seminiferous epithelium in normal rat testes with fluorescence confined to the basal region of the tubules, consistent with its localization at the BTB (Fig. 4 A and B ; the white broken line in Fig. 4B illustrates the relative BTB location in the seminiferous epithelium). However, when rats were treated with cadmium, which was known to perturb the BTB integrity (28, 29) , FITC was readily detected in the entire seminiferous epithelium beyond the BTB, and some fluorescence was seen detected at or near the tubule lumen by day 5 (Fig. 4 C and D) . In rats treated with vehicle only, fluorescence was restricted near the basement membrane and no FITC was detected beyond the BTB, similar to normal rats (Fig. 4 E vs. A and B) . However, in rats treated with CNP at doses of 0.35 or 3.5 g per testis, and the BTB integrity was assessed by 1 or 3 days, it was shown to be compromised (Fig. 4 F-N) . Although the damage to the BTB integrity was not as severe as rats treated with cadmium, green fluorescence was clearly detected inside the seminiferous epithelium beyond the BTB (Fig. 4 F-N vs.  A, B , and E). When these results were analyzed semiquantitatively by measuring the distance traveled by FITC beyond the BTB near the basement membrane (D FITC ) vs. the radius of the seminiferous tubule (D STr ), the diffusion of FITC in testes from rats treated with CNP was significantly greater than normal testes or vehicle control (Fig. 4O) . These results thus confirm the in vitro findings that an elevation of testicular CNP level affects BTB dynamics.
Discussion
In the seminiferous epithelium of adult rat testes, the BTB created by adjacent Sertoli cells near the basement membrane physically divides the epithelium into the basal and adluminal compartment so that postmeiotic germ cell development is segregated from the systemic circulation (26, 27) . It also confers cell polarity and restricts the diffusion of molecules from the interstitium into the seminiferous epithelium. Although BTB is one of the tightest blood-tissue barriers, preleptotene spermatocytes residing in the basal compartment must traverse the BTB at stage VIII of the epithelial cycle (30) , entering the adluminal compartment for further development. Thus, BTB undergoes extensive restructuring to facilitate preleptotene spermatocyte migration. However, the biochemical mechanisms that regulate this event have been unknown until recently. For instance, TNF␣ and TGF-␤3 produced by Sertoli and germ cells have recently been shown to modulate BTB dynamics (31) (32) (33) (34) . Both cytokines induced transient but reversible BTB disruption in adult rats (32, 33) , suggesting that their local production by Sertoli and germ cells plays a crucial role in ''opening'' the BTB to facilitate preleptotene spermatocyte migration.
Testosterone is also a regulator of Sertoli cell TJ permeability barrier function because its presence in Sertoli cells cultured in vitro was shown to facilitate the TJ barrier assembly (35, 36) . However, in vivo studies using an androgen suppression model by lowering the intratesticular androgen level in adult rats, thereby inducing elongating/elongate spermatid (step 8 and beyond) depletion from the seminiferous epithelium by perturbing the apical ectoplasmic specialization function, have shown that the BTB integrity was not compromised (37) . Recently, three mouse models were generated in which androgen receptor (AR) was selectively knocked out in Sertoli cells (SCARKO) (38) (39) (40) . These mice were produced by Cre/loxP technology where transgenic mice carrying an AR with a floxed exon 2 were crossed with mice expressing Cre-recombinase selectively in Sertoli cells regulated by the AMH (anti-Müllerian hormone) promoter (38) . Testes from these mice were shown to be markedly smaller, displaying a block in meiosis with fewer round spermatids and virtually no elongated spermatids, but the number of Sertoli cells and spermatogonia were similar to wild types. Interestingly, serum testosterone level in SCARKO mice was shown to be similar (38, 41) , 50% less (40), or 40-fold more (39) in different studies when compared with wild types. By using these AR knockout mice (39) as an in vivo model to examine the role of testosterone on BTB function, it was reported that androgen is a crucial regulator of BTB, which mediated its effects via claudin-3, which was the transcriptional target of ARs in Sertoli cells (42) . However, it must be noted that in this in vivo study (42) the SCARKO mice were made with a floxed exon 1, but the floxed animals had already displayed a marked hypomorphic phenotype and the ultimate AR knockout was neither complete nor Sertoli cell-selective (39) . Furthermore, the steady-state protein level of claudin-3 in adult rat testes was virtually nondetectable in contrast to the high levels seen in immature rats before 30 days of age (unpublished observations) (42) , illustrating that claudin-3 is highly unlikely to be an important androgen target protein at the BTB, at least in adult rats. Needless to say, although androgen was shown to regulate the levels of several BTB integral membrane proteins, such as occludin, claudin-3, and cadherins (18, 35, 36, 42) , work is needed to define its molecular targets at the BTB.
In this article we have demonstrated that CNP is a regulator of BTB dynamics in adult rat testes based on results of in vitro and in vivo studies. CNP and its receptor, NPR-B (or GC-B), are known regulators of renal and cardiovascular physiology; additionally, CNP Ϫ/Ϫ mice displayed dwarfism, and NPR-B Ϫ/Ϫ mice displayed phenotypes of dwarfism, female sterility, and decreased adiposity (for a review, see ref.
3). However, the effects of CNP on male testicular function, in particular BTB and anchoring junction dynamics and/or integrity, are not known. It is likely that CNP affects BTB integrity via its effects on the intracellular cGMP level in Sertoli cells because 8-bromo-cGMP (a cGMP analog which cannot be cleaved and inactivated by cGMP phosphodiesterase) was shown to disrupt the Sertoli cell TJ barrier function dose-dependently (17) . Recent studies have also shown that the effects of ANP on the endothelial TJ barrier function are also mediated via changes in the phosphorylation status of occludin and ZO-1 at the TJ site (16) . More important, NPR-A (or GC-B, the receptor of ANP) was recently shown to be predominantly localized in the seminiferous tubule instead of cells in the interstitium, such as Leydig cells in rat testes (43) . Different natriuretic peptides can exert differential effects on endothelial barrier function. For instance, ANP, but not CNP, is capable of blocking the thrombin-induced disruption of the rat lung microvascular endothelial barrier via a cGMPindependent, possibly Rho A-dependent, mechanism (44) . Thus, ANP may work in concert with CNP to regulate junction restructuring events during spermatogenesis. In this context, it is of interest to note that recent studies have shown that the secretion of CNP is up-regulated by TNF␣ (45) Fig. 5 , CNP produced by Sertoli and germ cells into the BTB microenvironment, such as at stage VIII of the epithelial cycle, may trigger intracellular signaling events via NPR-B. This, in turn, accelerates endocytosis of N-cadherin, occludin and JAM-A, the three BTB-associated integral-membrane proteins, lowering their steady-state levels at the BTB between adjacent Sertoli cells, opening the BTB transiently to facilitate preleptotene spermatocyte migration. In summary, CNP, a peptide hormone produced by cardiocytes known to regulate vascular dilation/constriction and permeability, is also produced locally in the testis by Sertoli cells, and serves as an autocrine factor to regulate BTB dynamics. Table 1 ] and cDNAs reverse-transcribed from rat testis RNA to serve as templates. The identity of the full-length clone was confirmed by direct nucleotide sequencing at Genewiz (North Brunswick, NJ). This cDNA was ligated to pGEM-T vector (Promega, Madison, WI), which was then excised from the SpeI/ SacII restriction endonuclease recognition sites within the pGEM-T vector and subcloned into pIRES2-DsRed2 (Clontech, Mountain View, CA) at the NheI/SacII sites, generating the pIRES2-DsRed2-CNP plasmid. The identity of the vector and the insert was verified by direct nucleotide sequencing at both directions before use. Primary Sertoli cells were transfected with pIRES2-DsRed2 or pIRES2-DsRed2-CNP by using Effectene reagent (Qiagen, Valencia, CA) essentially as earlier described with Ϸ15% efficiency (32) . Cells were used by 24 h after transient transfection.
Materials and Methods
PCR, Immunohistochemistry, Microscopy, and Immunoblotting. Semiquantitative RT-PCR and real-time PCR were performed as described in SI Table 1 . Immunohistochemistry was performed as described (37) . Fluorescent microscopy was performed by using an Olympus BX-40 microscope equipped with fluorescence optics, and images were acquired with an Olympus DP70 12.5 MPa Digital Camera. Immunoblot analysis was performed as described (32) . Confocal microscopy was performed at The Rockefeller University Bio-Imaging Resource Center with an inverted LSM 510 Laser Scanning confocal microscope (Zeiss, Thornwood, NY). Images were processed by using LSM 510 (version 3.2) software (Zeiss). Antibodies used for pertinent morphology and immunoblotting studies are listed in SI Table 2 .
Endocytosis Assay. Endocytosis assay was performed by cell surface biotinylation as described (25, 47) . Sertoli cells cultured for 4 days were washed with ice-cold PBS twice and incubated with 0.5 mg/ml sulfo-NHS-SS-Biotin (Pierce, Rockford, IL) in PBS/CM buffer [10 mM Na 2 HPO 4 and 2 mM KH 2 PO 4 (pH 7.4) at 22°C, containing 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl 2 , and 0.7 mM MgCl 2 ] at 4°C for 30 min to permit biotinylation of all cell surface proteins. This was followed by a quenching step using 50 mM NH 4 Cl in PBS/CM buffer at 4°C for 15 min. Cells were washed twice with PBS and incubated in F12/DMEM with (test) or without (control) CNP-22 peptide (10 Ϫ6 M) at 35°C for various durations to allow endocytosis of cell surface proteins. Thereafter, cells were washed in cold PBS, treated with a biotin-stripping buffer [50 mM MESNA in 100 mM Tris⅐HCl (pH 8.6) at 22°C, containing 100 mM NaCl and 2.5 mM CaCl 2 ] at 4°C for 30 min to remove remaining biotin on cell surface and quenched with 5 mg/ml iodoacetamide in PBS/CM buffer at 4°C for 15 min. After washing with PBS, cells were lysed in an IP lysis buffer [10 mM Tris (pH 7.4) at 22°C, containing 0.15 M NaCl, 2 mM PMSF, 1 mM EGTA, 1% Nonidet P-40 (vol/vol), 1 mM sodium orthovanadate, 1 g/ml leupeptin, 1 g/ml aprotinin, and 10% glycerol (vol/vol)]. Equal amounts of cell lysates were incubated with NeutrAvidin beads to pull down biotinylated proteins, and, after washing with PBS, biotinylated proteins were eluted in SDS sample buffer for immunoblotting using corresponding specific antibodies to assess the kinetics of protein internalization.
Functional BTB Integrity Assay. The integrity of the BTB was assessed in a functional assay by monitoring the ability of the BTB to restrict the diffusion of a small fluorescent probe across the barrier. In brief, adult rats (Ϸ270-300 g of body weight at Ϸ90-120 days of age) were treated with a low (0.35 g of peptide per testis; n ϭ 3 rats) or a high (3.5 g of peptide per testis; n ϭ 3 rats) dose of CNP-22 (CNP was prepared in saline, and each testis was at 1.6 Ϯ 0.13 g) via an intratesticular injection using a 27-gauge needle in a final volume of Ϸ150 l with Ϸ75 l per site (with a total of two sites per testis) (32, 48) at time 0, and rats were used by day 1 and day 3 thereafter for FITC infusion (see below). At these doses, if the peptide had dispersed throughout the testes uniformly, and assuming a testicular volume of 1.6 ml, a concentration of 10 Ϫ7 M or 10 Ϫ6 M would have been achieved; however, this might not be the case given the M r of the peptide (see SI Discussion). Controls included rats treated with saline alone (vehicle control, n ϭ 3), no treatment (n ϭ 3), or with CdCl 2 (3 mg/kg of body weight) via i.p. [positive control, n ϭ 2; terminated on day 5, which is known to induce BTB damage (28, 29) ]. At specified time points, rats were anesthetized. FITC (M r 389; AnaSpec, San Jose, CA) was reconstituted in DMSO and diluted in sterile saline. A total of 0.6 mg of FITC in a final volume of 200 l was administered to each rat via the jugular vein by using a 28-gauge needle. Rats were allowed to recover. Approximately 80 min after the infusion, rats were killed and testes were removed and frozen in liquid nitrogen. Frozen testes sections were obtained and examined by fluorescence microscopy. Tubules from each rat (a total of Ϸ200 tubules from two testes of different rats per treatment group were randomly selected) were photographed for each time point. To yield semiquantitative data to assess BTB integrity after CNP peptide treatment, the distance of FITC that was diffused into the seminiferous epithelium beyond the BTB in tubules from treatment groups vs. controls was measured and compared with the tubule radii (diffusion/radius). We did not quantify the concentration of CNP-22 in the testes, but, because BTB damage was detected almost across the entire testes as we randomly selected the tubules for scoring, we speculate that the CNP-22 peptide was distributed evenly in treated testes.
